Rise Advisors’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-389
Closed -$24.5K 517
2025
Q3
$24.5K Sell
389
-1,000
-72% -$69.8K 0.01% 462
2025
Q2
$104K Buy
1,389
+1,000
+257% +$78.6K 0.04% 151
2025
Q1
$34.3K Buy
389
+6
+2% +$567 0.02% 295
2024
Q4
$35K Hold
383
0.02% 328
2024
Q3
$42.9K Hold
383
0.02% 270
2024
Q2
$37.6K Hold
383
0.02% 298
2024
Q1
$38.4K Hold
383
0.02% 289
2023
Q4
$34.4K Sell
383
-131
-25% -$10.4K 0.02% 202
2023
Q3
$39.5K Buy
514
+1
+0.2% +$83 0.03% 160
2023
Q2
$43K Sell
513
-72
-12% -$5.85K 0.03% 161
2023
Q1
$49.3K Sell
585
-25
-4% -$2.15K 0.04% 151
2022
Q4
$49.7K Buy
610
+2
+0.3% +$161 0.04% 154
2022
Q3
$43K Buy
608
+2
+0.3% +$180 0.04% 167
2022
Q2
$54K Sell
606
-6
-1% -$621 0.05% 135
2022
Q1
$69K Buy
612
+1
+0.2% +$117 0.06% 120
2021
Q4
$73.8K Buy
+611
New +$67.9K 0.07% 118

Other funds holding EMN

Rise Advisors's EMN Position: Q4 2025 in Review

Rise Advisors sold out of Eastman Chemical (EMN) in Q4 2025, closing a stake of 389 shares — an estimated $24.5K sold.

Rise Advisors first reported a position in EMN in Q4 2021 and held it in 16 quarters. The position peaked at $104K in Q2 2025. 633 funds tracked by Wall St. Rank hold EMN as of Q4 2025.

  • Rise Advisors reported no remaining Eastman Chemical position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 389 Eastman Chemical shares in Q4 2025, an estimated $24.5K.
  • Rise Advisors first reported a position in Eastman Chemical in Q4 2021 and held it in 16 quarters.
  • Rise Advisors's Eastman Chemical position peaked at $104K in Q2 2025.
  • 633 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.